Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction

Wang, YL; Bai, L; Shi, XR; Zhu, H; Du, LJ; Liu, Y; Ma, XX; Lin, WZ; Liu, T; Sun, JY; Liu, Y; Guo, XG; Zhou, LJ; Chen, BY; Shao, S; Meng, XQ; Li, YL; Li, RG; Duan, SZ

Li, RG (通讯作者)，Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, 241 West Huaihai Rd, Shanghai 200030, Peoples R China.;Duan, SZ (通讯作者)，Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Res Ctr, Sch Med, 115 Jinzun Rd, Shanghai 200125, Peoples R China.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022; 167 (): 40

Abstract

Rationale: Mineralocorticoid receptor (MR) antagonists have been clinically used to treat heart failure. However, the underlying cellular and molecula......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索